Association between gallstones and the risk of biliary tract cancer risk: a systematic review and meta-analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Biliary tract cancers (BTCs) are rare but highly fatal. Although the etiology of BTC is poorly understood, gallstones are proposed to be a major risk factor. We conducted a systematic review and meta-analysis to examine the associations between gallstone characteristics and BTC risk. METHODS: We searched the MEDLINE, Embase, and Cochrane Central databases and systematically reviewed cohort and case-control studies published before April 9, 2018. All the included studies reported appropriate risk estimates and confidence intervals (CIs) for associations between the presence, size, number, or duration of gallstones and the risk of BTC, including gallbladder cancer (GBC), extrahepatic bile duct cancer (EBDC), and ampulla of Vater cancer (AOVC). Summary odds ratios (ORs) and their 95% CIs were calculated using a random-effects model in the meta-analysis. Subgroup analyses were conducted to inspect sources of potential heterogeneity, and the Egger test was performed to assess publication bias. RESULTS: Seven cohort studies and 23 case-control studies in Asian, European, and American populations were included. The presence of gallstones was associated with an increased risk of BTC (OR, 4.38; 95% CI, 3.23 to 5.93; I2=91.2%), GBC (OR, 7.26; 95% CI, 4.33 to 12.18), EBDC (OR, 3.17; 95% CI, 2.24 to 4.50), and AOVC (OR, 3.28; 95% CI, 1.33 to 8.11). Gallstone size (>1 vs. <1 cm; OR, 1.88; 95% CI, 1.10 to 3.22) was significantly associated with the risk of GBC. CONCLUSIONS: Gallstone characteristics, such as presence, size, and number, are associated with an increased risk of BTC. However, significantly high heterogeneity in the meta-analyses is a limitation of this study.
Abstract
OBJECTIVES: Biliary tract cancers (BTCs) are rare but highly fatal. Although the etiology of BTC is poorly understood, gallstones are proposed to be a major risk factor. We conducted a systematic review and meta-analysis to examine the associations between gallstone characteristics and BTC risk. METHODS: We searched the MEDLINE, Embase, and Cochrane Central databases and systematically reviewed cohort and case-control studies published before April 9, 2018. All the included studies reported appropriate risk estimates and confidence intervals (CIs) for associations between the presence, size, number, or duration of gallstones and the risk of BTC, including gallbladder cancer (GBC), extrahepatic bile duct cancer (EBDC), and ampulla of Vater cancer (AOVC). Summary odds ratios (ORs) and their 95% CIs were calculated using a random-effects model in the meta-analysis. Subgroup analyses were conducted to inspect sources of potential heterogeneity, and the Egger test was performed to assess publication bias. RESULTS: Seven cohort studies and 23 case-control studies in Asian, European, and American populations were included. The presence of gallstones was associated with an increased risk of BTC (OR, 4.38; 95% CI, 3.23 to 5.93; I2=91.2%), GBC (OR, 7.26; 95% CI, 4.33 to 12.18), EBDC (OR, 3.17; 95% CI, 2.24 to 4.50), and AOVC (OR, 3.28; 95% CI, 1.33 to 8.11). Gallstone size (>1 vs. <1 cm; OR, 1.88; 95% CI, 1.10 to 3.22) was significantly associated with the risk of GBC. CONCLUSIONS: Gallstone characteristics, such as presence, size, and number, are associated with an increased risk of BTC. However, significantly high heterogeneity in the meta-analyses is a limitation of this study.
참고문헌 (57)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- "Cancer incidence in five continents Vol. X" (2014)[URL]
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- Shaib Y, "The epidemiology of cholangiocarcinoma", Semin Liver Dis, 24, pp.115~125 (2004)
- Randi G, "Epidemiology of biliary tract cancers : an update", Ann Oncol, 20, pp.146~159 (2009)
- Anderson CD, "Diagnosis and treatment of cholangiocarcinoma", Oncologist, 9, pp.43~57 (2004)
- Misra S, "Carcinoma of the gallbladder", Lancet Oncol, 4, pp.167~176 (2003)
- 이상훈, "췌장암과 담관암에서의 염증과 발암", 대한소화기학회지, 66(6), pp.325~339 (2015), 대한소화기학회
- Schottenfeld D, "Chronic inflammation : a common and important factor in the pathogenesis of neoplasia", CA Cancer J Clin, 56, pp.69~83 (2006)
- Laura M. Stinton, "Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer", Gut and Liver, 6(2), pp.172~187 (2012), 거트앤리버 소화기연관학회협의회[DOI]
- Flood TA, "Malignant tumours of gallbladder and extrahepatic bile ducts", Diagn Histopathol, 16, pp.360~370 (2010)
- Nordenstedt H, "Gallstones and cholecystectomy in relation to risk of intra-and extrahepatic cholangiocarcinoma", Br J Cancer, 106, pp.1011~1015 (2012)
- He XD, "Association of metabolic syndromes and risk factors with ampullary tumors development : a case-control study in China", World J Gastroenterol, 20, pp.9541~9548 (2014)
- Randi G, "Gallbladder cancer worldwide : geographical distribution and risk factors", Int J Cancer, 118, pp.1591~1602 (2006)
- de Groen PC, "Biliary tract cancers", N Engl J Med, 341, pp.1368~1378 (1999)
- Zeng X, "The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline : a systematic review", J Evid Based Med, 8, pp.2~10 (2015)
- Borenstein M, "Introduction to meta‐analysis", pp.69~75 (2009), John Wiley & Sons
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Patsopoulos NA, "Sensitivity of betweenstudy heterogeneity in meta-analysis : proposed metrics and empirical evaluation", Int J Epidemiol, 37, pp.1148~1157 (2008)
- Sedgwick P, "How to read a funnel plot in a meta-analysis", BMJ, 351, pp.h4718~ (2015)
- Egger M, "Bias in metaanalysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Maringhini A, "Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota", Ann Intern Med, 107, pp.30~35 (1987)
- Bansal P, "Comorbid occurrence of cholelithiasis and gastrointestinal cancer", Eur J Gastroenterol Hepatol, 8, pp.985~988 (1996)
- Chow WH, "Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas", Br J Cancer, 79, pp.640~644 (1999)
- Zou S, "Relative risk factors analysis of 3, 922 cases of gallbladder cancer", Zhonghua Wai Ke Za Zhi, 38, pp.805~808 (2000)
- Ishiguro S, "Risk factors of biliary tract cancer in a large-scale populationbased cohort study in Japan(JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification", Cancer Causes Control, 19, pp.33~41 (2008)
- Lai HC, "Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study", J Gastroenterol, 48, pp.856~865 (2013)
- Diehl AK, "Gallstone size and the risk of gallbladder cancer", JAMA, 250, pp.2323~2326 (1983)
- Lowenfels AB, "Gallstones and risk of gallbladder cancer", J Natl Cancer Inst, 75, pp.77~80 (1985)
- Lowenfels AB, "Gallstone growth, size, and risk of gallbladder cancer : an interracial study", Int J Epidemiol, 18, pp.50~54 (1989)
- Moerman CJ, "Gallstone size and the risk of gallbladder cancer", Scand J Gastroenterol, 28, pp.482~486 (1993)
- Khan ZR, "Risk factors for biliary tract cancers", Am J Gastroenterol, 94, pp.149~152 (1999)
- Okamoto M, "Ultrasonographic evidence of association of polyps and stones with gallbladder cancer", Am J Gastroenterol, 94, pp.446~450 (1999)
- Welzel TM, "Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States : a population-based case-control study", Clin Gastroenterol Hepatol, 5, pp.1221~1228 (2007)
- Hsing AW, "Gallstones and the risk of biliary tract cancer : a populationbased study in China", Br J Cancer, 97, pp.1577~1582 (2007)
- Ahrens W, "Risk factors for extrahepatic biliary tract carcinoma in men : medical conditions and lifestyle : results from a European multicentre case–control study", Eur J Gastroenterol Hepatol, 19, pp.623~630 (2007)
- Grainge MJ, "The antecedents of biliary cancer : a primary care case-control study in the United Kingdom", Br J Cancer, 100, pp.178~180 (2009)
- Tao LY, "Risk factors for intrahepatic and extrahepatic cholangiocarcinoma : a case-control study in China", Liver Int, 30, pp.215~221 (2010)
- Cai WK, "Risk factors for hilar cholangiocarcinoma : a case-control study in China", World J Gastroenterol, 17, pp.249~253 (2011)
- Alvi AR, "Risk factors of gallbladder cancer in Karachi-a case-control study", World J Surg Oncol, 9, pp.164~ (2011)
- Wu Q, "The metabolic syndrome and risk factors for biliary tract cancer : a case-control study in China", Asian Pac J Cancer Prev, 13, pp.1963~1969 (2012)
- Onal IK, "Hepatitis B and C virus infection and cholangiocarcinoma : a case-control study in Turkey", Int J Hematol Oncol, 22, pp.187~191 (2012)
- Chang JS, "Medical risk factors associated with cholangiocarcinoma in Taiwan : a population-based case-control study", PLoS One, 8, pp.e69981~ (2013)
- Nogueira L, "Gallstones, cholecystectomy, and risk of digestive system cancers", Am J Epidemiol, 179, pp.731~739 (2014)
- Cha BH, "Epidemiological characteristics of gallbladder cancer in Jeju Island : a single-center, clinically based, age-sex-matched, case-control study", Asian Pac J Cancer Prev, 16, pp.8451~8454 (2015)
- Lee BS, "Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development : a case-control study in Korea", World J Gastroenterol, 21, pp.502~510 (2015)
- Lee BS, "Risk factors for perihilar cholangiocarcinoma : a hospital-based case-control study", Liver Int, 35, pp.1048~1053 (2015)
- Rosato V, "Medical conditions, family history of cancer, and the risk of biliary tract cancers", Tumori, 2016, pp.252~257 (2016)
- Tamrakar D, "Risk factors for gallbladder cancer in Nepal a case control study", Asian Pac J Cancer Prev, 17, pp.3447~3453 (2016)
- Magouliotis DE, "Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery : an updated systematic review and meta-analysis", Obes Surg, 27, pp.3021~3030 (2017)
- Godrey PJ, "Gall stones and mortality : a study of all gall stone related deaths in a single health district", Gut, 25, pp.1029~1033 (1984)
- Moerman CJ, "Reproductive history and cancer of the biliary tract in women", Int J Cancer, 57, pp.146~153 (1994)
- Zatonski WA, "Epidemiologic aspects of gallbladder cancer : a case-control study of the SEARCH Program of the International Agency for Research on Cancer", J Natl Cancer Inst, 89, pp.1132~1138 (1997)
- Serra I, "Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population", Int J Cancer, 102, pp.407~411 (2002)
- WHO Collaborative Study of Neoplasia, "Combined oral contraceptives and gallbladder cancer", Int J Epidemiol, 18, pp.309~314 (1989)
- Yagyu K, "Bowel movement frequency, medical history and the risk of gallbladder cancer death : a cohort study in Japan", Cancer Sci, 95, pp.674~678 (2004)
- Gupta A, "Epidemiology and risk factors : intrahepatic cholangiocarcinoma", Hepatobiliary Surg Nutr, 6, pp.101~104 (2017)